Language
English
Login
We offer our registered users tailored information, free online courses and exclusive content.
Can't find your password?
Reset it here.
Reset it here.
MS Academia: Multiple sclerosis advanced course
PART OF MS Alumni FEATURE
MS Academia: Multiple sclerosis advanced course
- Neurology
- Multiple sclerosis
Tuesday, Sep 13 2016
London, United Kingdom
Registration status
Closed
To register for this event, contact
Meridiano Congress International
Congress Manager: Sara Guglielmini
T +39 06 88 595 211 - F +39 06 88 595 234
sara.guglielmini@meridiano.it
Registration fee
200.00€
The registration fee is € 200,00 and includes:
- Scientific sessions
- Coffee breaks and luncheon
- Educational materials
- Certificate of attendance
Target audiences
This programme is appropriate for neurologists who specialize in MS as well as other clinicians with a special interest or focus on this disease.
Files
Introduction
Access the post-event resources by scrolling down to the Scientific Programme or by clicking on the Outcomes tab.
This live educational course is endorsed by ECTRIMS (European Committee for Treatment and Research In Multiple Sclerosis).
Overview
Multiple sclerosis (MS) is a multifaceted neurological disorder whose management requires a multidisciplinary team of highly specialised health professionals. The availability of new and sophisticated diagnostic tools and the discovery of new treatments has made daily clinical practice even more challenging for physicians involved in MS patient management. Tailoring the treatment to individual patient needs and establishing the right time to start therapy or to switch from traditional first-line disease-modifying therapies to other first- or second-line therapies are the biggest issues. The goal of this learning activity is to update participants about MS pathogenesis and diagnostic criteria and to provide a comprehensive overview of past and future disease-modifying therapies. In addition, the learner will be taught about strategies for symptomatic and rehabilitative care which have proven to be a necessity in overall MS management. A clinical cases based approach will be used to stimulate discussion and scientific exchange between participants and the panel of MS experts.
Learning objectives
- Illustrate the immunological factors involved in the pathogenesis of multiple sclerosis
- Integrate clinical, neurophysiological, and MRI findings into the accurate diagnosis of multiple sclerosis and the exclusion of MS mimickers
- Incorporate information regarding the risks and benefits of currently available drugs for multiple sclerosis into treatment decisions
- Include symptomatic management of multiple sclerosis into the treatment paradigm of comprehensive management throughout the spectrum of the disease
Accreditation details
The EXCEMED “MS Academia: Multiple sclerosis advanced course” is accredited by the European Accreditation Council for
Continuing Medical Education (EACCME ® ) to provide the following CME activity for medical specialists. The EACCME ® is an
institution of the European Union of Medical Specialists (UEMS), www.uems.net
The CME “MS Academia: Multiple sclerosis advanced course” held on 13 September 2016 in London, UK, is designated for a
maximum of 6 (six) hours of European external CME credits (ECMEC). Each medical specialist should claim only those credits that
he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may
convert EACCME ® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert
EACCME ® credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be
Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of
Physicians and Surgeons of Canada.
Scientific programme
Tuesday, 13 September 2016
08.15 Opening and introduction
G. Comi (Italy) - H.P. Hartung (Germany) - F.D. Lublin (USA)
Session I: Etiology and pathogenisis
Chairs: H.P. Hartung (Germany) - F.D. Lublin (USA)
08.30 L1: Genes, J. Hillert (Sweden)
Slide presentation Video
09.00 L2: Environmental factors and microbiota, A. Ascherio (USA)
09.30 L3: Pathology, W. Brück (Germany)
Slide presentation Video
10.00 L4: Immunopathogenesis: the crosstalk between B and T cells, A. Bar-Or (Canada)
Slide presentation Video
10.30 Session discussion
10.40 Coffee break
Session II: Diagnosis. Case based story session
Chairs: G. Comi (Italy) - F. D. Lublin (USA)
This session will propose a practice-based approach to the key elements of MS diagnosis. Presenters will offer actual examples from their own clinical experiences to effectively illuminate the most important diagnostic elements of MS.
11.00 CBS1: Diagnosis and differential diagnosis, M. Tintoré (Spain)
Slide presentation Video
11.30 CBS2: MRI in diagnosis and monitoring of MS and treatments, M.A. Rocca (Italy)
Slide presentation Video
12.00 CBS3: Neurophysiology in diagnosis and monitoring of MS, L. Leocani (Italy)
Slide presentation Video
12.30 L5: Assessment of treatment response, R. Fox (USA)
Slide presentation Video
13.00 Session discussion
13.10 Lunch
Session III: Treatment
Chairs: H.P. Hartung (Germany) - G. Comi (Italy)
14.20 L6: Efficacy and safety of immunomodulators in RR MS, M.S. Freedman (Canada)
Slide presentation Video
14.50 L7: Efficacy and safety of immunosuppressants in RR MS, G. Giovannoni (UK)
Slide presentation Video
15.20 Coffee break
15.40 L8: Treatment individualization and new treatment algorithms, G. Comi (Italy)
Slide presentation Video
16.10 L9: Pharmacological and non pharmacological approach to progressive MS, A. J. Thompson (UK)
16.40 L10: Future therapies, H. P. Hartung (Germany)
17.10 Session discussion
17.20 PD: Treatment in Practice – Panel discussion
G. Comi (Italy); M. Freedman (Canada); G. Giovannoni (UK); F. Lublin (USA)
17.50 Concluding remarks
End of the course
CME provider
EXCEMED - Excellence in Medical Education
Programme Manager: Giulia Anastasia
T +39 06 420413 315 - F +39 06 420413 677
giulia.anastasia@excemed.org
Medical Advisor: Doriana Landi
doriana.landi@gmail.com
Chair(s)
Giancarlo Comi
Vita-Salute San Raffaele University
Milan, Italy
Hans Peter Hartung
Director of the Center for Neuropsychiatry and Chair of the Department of Neurology
Department of Neurology
Heinrich-Heine-University Duesseldorf
Dusseldorf, Germany
Fred D. Lublin
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States
Speakers
Alberto Ascherio
Professor of Epidemiology and Nutrition; Professor of Medicine
Department of Epidemology and Nutrition
Harvard T.H. Chan School of Public Health
655 Huntington Avenue
Building II 3rd Floor
Boston, Massachusetts, 02115, United States
Amit Bar-Or
Neurologist and Professor
Department of Neurology and Neurosurgery
Clinical Research Unit
Montreal Neurological Institute
Montreal, Canada
Wolfgang Brück
Dean of Research and Infrastructure
Faculty of Medicine
Georg-August University
Göttingen, Germany
Professor of Neuropathology and Director of the Department of Neuropathology
Institute of Neuropathology
University Medical Centre Göttingen
Giancarlo Comi
Vita-Salute San Raffaele University
Milan, Italy
Mark Freedman
Professor of Medicine
Neurology
University of Ottawa
Ottawa, Canada
Senior Scientist and Director of the Multiple Sclerosis Research Unit
Multiple Sclerosis Research Unit
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Robert James Fox
Mellen Center for MS
Cleveland Clinic
Cleveland, Ohio, United States
Gavin Giovannoni
Chair of Neurology
Department of Neurology
Institute of Cell and Molecular Science
Queen Mary University London & Barts and The London NHS Trust
London, United Kingdom
Hans Peter Hartung
Director of the Center for Neuropsychiatry and Chair of the Department of Neurology
Department of Neurology
Heinrich-Heine-University Duesseldorf
Dusseldorf, Germany
Jan Hillert
Department of Clinical Neuroscience
Karolinska Institute
Stockholm, Sweden
Letizia Leocani
Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy
Fred D. Lublin
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States
Maria Assunta Rocca
Head of the “Neuroimaging of CNS White Matter Unit”
Department of Neurology
Institute of Experimental Neurology
Milan, Italy
Alan Thompson
Department of Brain Repair and Rehabilitation
Institute of Neurology
National Hospital for Neurology and Neurosurgery
Queen Square
London, United Kingdom
Mar Tintorè
Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain
